{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:47:51Z","timestamp":1791161271717,"version":"4.1.0"},"reference-count":25,"publisher":"BMJ","issue":"6488","license":[{"start":{"date-parts":[[1985,7,13]],"date-time":"1985-07-13T00:00:00Z","timestamp":490060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Med J (Clin Res Ed)"],"published-print":{"date-parts":[[1985,7,13]]},"abstract":"<jats:p>The main aim of the trial was to determine whether drug treatment of mild hypertension (phase V diastolic pressure 90-109 mm Hg) reduced the rates of stroke, of death due to hypertension, and of coronary events in men and women aged 35-64 years. Subsidiary aims were: to compare the course of blood pressure in two groups, one taking bendrofluazide and one taking propranolol, and to compare the incidence of suspected adverse reactions to these two drugs. The study was single blind and based almost entirely in general practices; 17 354 patients were recruited, and 85 572 patient years of observation have accrued. Patients were randomly allocated at entry to take bendrofluazide or propranolol or placebo tablets. The primary results were as follows. The stroke rate was reduced on active treatment: 60 strokes occurred in the treated group and 109 in the placebo group, giving rates of 1.4 and 2.6 per 1000 patient years of observation respectively (p less than 0.01 on sequential analysis). Treatment made no difference, however, to the overall rates of coronary events: 222 events occurred on active treatment and 234 in the placebo group (5.2 and 5.5 per 1000 patient years respectively). The incidence of all cardiovascular events was reduced on active treatment: 286 events occurred in the treated group and 352 in the placebo group, giving rates of 6.7 and 8.2 per 1000 patient years respectively (p less than 0.05 on sequential analysis). For mortality from all causes treatment made no difference to the rates. There were 248 deaths in the treated group and 253 in the placebo group (rates 5.8 and 5.9 per 1000 patient years respectively). Several post hoc analyses of subgroup results were also performed but they require very cautious interpretation. The all cause mortality was reduced in men on active treatment (157 deaths versus 181 in the placebo group; 7.1 and 8.2 per 1000 patient years respectively) but increased in women on active treatment (91 deaths versus 72; 4.4 and 3.5 per 1000 patient years respectively). The difference between the sexes in their response to treatment was significant (p = 0.05). Comparison of the two active drugs showed that the reduction in stroke rate on bendrofluazide was greater than that on propranolol (p = 0.002). The stroke rate was reduced in both smokers and non-smokers taking bendrofluazide but only in non-smokers taking propranolol. This difference between the responses to the two drugs was significant (p = 0.03).(ABSTRACT TRUNCATED AT 400 WORDS)<\/jats:p>","DOI":"10.1136\/bmj.291.6488.97","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T11:00:59Z","timestamp":1238670059000},"page":"97-104","source":"Crossref","is-referenced-by-count":1385,"title":["MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party."],"prefix":"10.1136","volume":"291","member":"239","published-online":{"date-parts":[[1985,7,13]]},"reference":[{"key":"ref_1","first-page":"1437","volume":"ii:","unstructured":";ii:1437-40."},{"key":"ref_2","first-page":"235","article-title":"The role of blood pressure control in preventing complications of hypertension","volume":"i:","author":"Hamilton, M.; Thompson, E.N.; Wisniewski, T.K.M.","year":"1964","unstructured":"Hamilton M, Thompson EN, Wisniewski TKM. The role of blood pressure control in preventing complications of hypertension. Lancet 1964;i:235-8.","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/jama.1967.03130240070013","article-title":"Veterans Administration Co-operative Study Group. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg","volume":"202","year":"1967","unstructured":"Veterans Administration Co-operative Study Group. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967;202:1028-34.","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(70)91577-1","article-title":"Hypotensive therapy in stroke survivors","volume":"i:","author":"Carter, A.B.","year":"1970","unstructured":"Carter AB. Hypotensive therapy in stroke survivors. Lancet 1970;i:485-9.","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/jama.1970.03170330025003","article-title":"Veterans Administration Co-operative Study Group. Effects of treatment on morbidity in hypertension II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg","volume":"213","year":"1970","unstructured":"Veterans Administration Co-operative Study Group. Effects of treatment on morbidity in hypertension II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970;213:1143-52.","journal-title":"JAMA"},{"key":"ref_6","first-page":"595","article-title":"Screening for hypertension: some epidemiological observations","volume":"iii:","author":"Miall, W.E.; Chinn, S.","year":"1974","unstructured":"Miall WE, Chinn S. Screening for hypertension: some epidemiological observations. Br MedJ7 1974;iii:595-600."},{"key":"ref_7","author":"General, Registrar","year":"1970","unstructured":"Registrar General. Statistical Review of England and Wales, 1970. London: HMSO, 1971.","journal-title":"Statistical Review of England and Wales"},{"key":"ref_8","first-page":"38","article-title":"Observations on the natural history of mild hypertension in the control groups of therapeutic trials","volume-title":"hypertension, natural history and management","author":"Miall, W.E.; Brennan, P.J.","year":"1979","unstructured":"Miall WE, Brennan PJ. Observations on the natural history of mild hypertension in the control groups of therapeutic trials. In: Gross F, Strasser T, eds. Mild hypertension, natural history and management. Tunbridge Wells: Pitman Medical, 1979:38-43."},{"key":"ref_9","first-page":"337","article-title":"A random-zero sphygmomanometer","volume":"i:","author":"Wright, B.M.; Dore, C.F.","year":"1970","unstructured":"Wright BM, Dore CF. A random-zero sphygmomanometer. Lancet 1970;i: 337-8.","journal-title":"Lancet"},{"key":"ref_10","first-page":"296","article-title":"A sphygmomanometer for epidemiologists","volume":"i:","author":"Rose, G.A.; Holland, W.W.; Crowley, E.A.","year":"1964","unstructured":"Rose GA, Holland WW, Crowley EA. A sphygmomanometer for epidemiologists. Lancet 1964;i:296-300.","journal-title":"Lancet"},{"key":"ref_11","first-page":"113","article-title":"Cerebrovascular disease in the community; results of a WHO collaborative study","volume":"58","author":"Aho, H.; Harmsen, P.; Hatano, S.; Marquardsen, W.; Smirnov, V.E.; Strasser, T.","year":"1980","unstructured":"Aho H, Harmsen P, Hatano S, Marquardsen W, Smirnov VE, Strasser T. Cerebrovascular disease in the community; results of a WHO collaborative study. Bull WHO 1980;58:113-30.","journal-title":"Bull WHO"},{"key":"ref_12","article-title":"World Health Organisation Regional Office for Europe. Myocardial infarction community registers","volume-title":"Public Health in Europe No 5","year":"1976","unstructured":"World Health Organisation Regional Office for Europe. Myocardial infarction community registers. Copenhagen: WHO, 1976. (Public Health in Europe No 5.)"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/biomet\/64.2.191","article-title":"Group sequential methods in the design and analysis of clinical trials","volume":"64","author":"Pocock, S.J.","year":"1977","unstructured":"Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977;64:191-8.","journal-title":"Biometrika"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/bmj.290.6461.39","article-title":"Current issues in the design and interpretation of clinical trials","volume":"290","author":"Pocock, S.J.","year":"1985","unstructured":"Pocock SJ. Current issues in the design and interpretation of clinical trials. Br MedJa 1985;290:39-42.","journal-title":"Br MedJa"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/bmj.285.6346.919","article-title":"Seasonal variation in arterial blood pressure","volume":"285","author":"Brennan, P.J.; Greenberg, G.; Miall, W.E.; Thompson, S.G.","year":"1982","unstructured":"Brennan PJ, Greenberg G, Miall WE, Thompson SG. Seasonal variation in arterial blood pressure. Br MedJa 1982;285:919-23.","journal-title":"Br MedJa"},{"key":"ref_16","first-page":"539","article-title":"Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension","volume":"ii:","author":"Council, Medical Research","year":"1981","unstructured":"Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 1981;ii:539-43.","journal-title":"Lancet"},{"key":"ref_17","first-page":"149","article-title":"WHO\/ISH Mild Hypertension Liaison Committee. Trials of the treatment of mild hypertension. An interim analysis","volume":"i:","year":"1982","unstructured":"WHO\/ISH Mild Hypertension Liaison Committee. Trials of the treatment of mild hypertension. An interim analysis. Lancet 1982;i:149-56.","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00004872-198410000-00018","article-title":"The effect of smoking on blood pressure in mild hypertensives, and on their response to antihypertensive treatment","volume":"2","author":"Greenberg, G.; Thompson, S.G.","year":"1984","unstructured":"Greenberg G, Thompson SG. The effect of smoking on blood pressure in mild hypertensives, and on their response to antihypertensive treatment. Journal of Hypertension 1984;2:553.","journal-title":"Journal of Hypertension"},{"key":"ref_19","first-page":"1249","article-title":"Working Party on Mild to Moderate Hypertension. Ventricular extrasystoles during thiazide treatment: sub-study of MRC mild hypertension trial","volume-title":"Br MedJ3","volume":"287","author":"Council, Medical Research","year":"1983","unstructured":"Medical Research Council Working Party on Mild to Moderate Hypertension. Ventricular extrasystoles during thiazide treatment: sub-study of MRC mild hypertension trial. Br MedJ3 1983;287:1249-53."},{"key":"ref_20","first-page":"1465","article-title":"Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial. Risk Factor Changes and Mortality Results","volume":"248","year":"1982","unstructured":"Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial. Risk Factor Changes and Mortality Results. 7AMA 1982;248:1465-77."},{"key":"ref_21","first-page":"1261","article-title":"Australian therapeutic trial in mild hypertension","volume":"i:","year":"1980","unstructured":"Australian therapeutic trial in mild hypertension. Lancet 1980;i:1261-7.","journal-title":"Lancet"},{"key":"ref_22","article-title":"Reduction in mortality of persons with high blood pressure, including mild hypertension","unstructured":"Reduction in mortality of persons with high blood pressure, including mild hypertension."},{"key":"ref_23","first-page":"2562","article-title":"Mortality by race\/sex and age","volume":"242","year":"1979","unstructured":"Mortality by race\/sex and age. JAMA 1979;242:2562-77.","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/01.HYP.3.2.192","article-title":"Management of the hypertensive patient: a continuing dilemma","volume":"3","author":"Alderman, M.H.; Madhavan, S.","year":"1981","unstructured":"Alderman MH, Madhavan S. Management of the hypertensive patient: a continuing dilemma. Hypertension 1981;3:192-7.","journal-title":"Hypertension"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0002-9343(83)90354-6","article-title":"Conflicting clinical trials and the uncertainty of treating mild hypertension","volume":"75","author":"Toth, P.J.; Horwitz, R.I.","year":"1983","unstructured":"Toth PJ, Horwitz RI. Conflicting clinical trials and the uncertainty of treating mild hypertension. Am I Med 1983;75:482-8.","journal-title":"Am I Med"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.291.6488.97","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.291.6488.97","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T17:53:36Z","timestamp":1765475616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.291.6488.97"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,7,13]]},"references-count":25,"journal-issue":{"issue":"6488","published-online":{"date-parts":[[1985,7,13]]},"published-print":{"date-parts":[[1985,7,13]]}},"alternative-id":["10.1136\/bmj.291.6488.97"],"URL":"https:\/\/doi.org\/10.1136\/bmj.291.6488.97","relation":{},"ISSN":["0267-0623","1468-5833"],"issn-type":[{"value":"0267-0623","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,7,13]]}}}